From pioneering research to today’s focus on induced pluripotent stem cell science.
SINCE 2008ESTABLISHED
CELLULAR SCIENCE JOURNEY
ASIA-PACIFICPRIVATE CLIENT FOCUS
Our Journey
A CONTINUOUS PURSUIT OF SCIENTIFIC INNOVATION.
2000
Organ Cell
Organ-derived cellular materials in the legacy technology sequence.
2007
Mesenchymal Stem Cells (MSCs)
A focus on multipotent adult stem cells and their differentiation potential.
2010
Embryonic Stem Cells (ESCs)
Pluripotent cells, with ethical and immune considerations.
2015
Induced Pluripotent Stem Cells (iPSCs)
Adult-cell reprogramming and pluripotent cellular science.
Today
iPSC 3.0
Our current focus on induced pluripotent stem cell science.
Technology sequence and dates: Swiss Stem Cell timeline. Historical technology stages are distinct from company establishment in 2008.
Who We Are
Swiss Stem Cell™ is focused on cellular science, regenerative medicine education and personalised private-client coordination.
Our work brings together cellular science education, responsible communication and private-client coordination. We aim to make scientific information clear while distinguishing research potential from established clinical evidence.
With a long-term scientific outlook, we respect individual needs and support informed conversations about regenerative wellness. Research developments are not guarantees of treatment outcomes.
Our Values
Guided by our principles, driven by a healthier tomorrow.
Responsible Practice
Suitability, evidence and clear communication.
Science-Driven
Distinguish research from clinical claims.
People-Centred
Respect individual needs and priorities.
Integrity
Be clear about what is known and what needs verification.
Global Presence
Serving private clients across key Asia-Pacific markets.
Singapore
Malaysia
Brunei
Indonesia
Philippines
Thailand
Vietnam
Cambodia
China
Hong Kong
Macau
Taiwan
Medical Advisory Board
International expertise. A shared commitment to responsible private-client coordination.
